CMS updated its drug spending dashboards with pricing and spending data from 2017 to help increase transparency in healthcare and provide incentives to lower list prices.
The updated dashboards contain additional information about the drugmakers responsible for price increases, as well as pricing and spending data for thousands more drugs purchased by Medicaid and Medicare parts B and D.
The dashboards reveal average spending per dosage unit for prescription drugs under the government programs and track changes in average spending per dosage over time.
"Today's update to the drug dashboards continues the Trump Administration's commitment to price transparency. The dashboards pinpoint the sources of rising prescription drug prices to help guide our continued work to address this problem," said CMS Administrator Seema Verma.
Read the full news release here.